We combine two technology platforms to create new glyco-engineered monoclonal antibodies which identify unique target epitopes
A combined experience exceeding 100 years. Expertise in antibody engineering and process development.
Well-equipped 14,785 sqft Lab for complete process development. ISO 9001:2008 Certified
A number of provisional patents focusing on novel biomolecules and biosimilars filed.
Zumutor Biologics Inc. is a niche, innovation driven biologics company registered in the state of Delaware, with its office in Woburn, MA. Expertise and acumen of the Zumutor team is focused on development of new products through patent-pending technology platforms in our state of the art R&D facility in India
Zumutor also offers differentiated services ranging from co-development of monoclonal antibodies to recombinant technology based biosimilars